Novel therapeutics in rare genetic obesities: A narrative review.

Dubern B, Faccioli N, Poitou C, Clément K

Open source

DOI
10.1016/j.phrs.2023.106763
Published
2023 May
Container
Pharmacological research
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.phrs.2023.106763,
  title = {Novel therapeutics in rare genetic obesities: A narrative review.},
  author = {Dubern B and Faccioli N and Poitou C and Clément K},
  year = {2023},
  journal = {Pharmacological research},
  doi = {10.1016/j.phrs.2023.106763},
  url = {https://doi.org/10.1016/j.phrs.2023.106763}
}

RIS

TY  - JOUR
TI  - Novel therapeutics in rare genetic obesities: A narrative review.
AU  - Dubern B
AU  - Faccioli N
AU  - Poitou C
AU  - Clément K
PY  - 2023
JO  - Pharmacological research
DO  - 10.1016/j.phrs.2023.106763
UR  - https://doi.org/10.1016/j.phrs.2023.106763
ER  - 

APA

B, D., N, F., C, P., & K, C. (2023). Novel therapeutics in rare genetic obesities: A narrative review.. Pharmacological research. https://doi.org/10.1016/j.phrs.2023.106763

Source records